PLPeter Y. Liu

Peter Y. Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Y. Liu has a total of 518 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biological Mechanisms Underlying the Adverse Health Consequences of Human Circadian Misalignment from Night Shift Work

    by Kirsie R. Lundholm, Brieann C. Satterfield, Siobhan Banks, Peter Y. Liu, Chathuri J. Kombala, Gabriela Hurtado-Alvarado, Adam J. Greer, Rachael A. Muck, Matthew A. Layton, Dan Du, et al.

    Purpose of Review The waking and working times of night shift workers are displaced relative to the natural light/dark cycle, putting behavioral patterns in misalignment with the circadian regulation of biological processes. This state of circadian misalignment constitutes a circadian health problem, with widespread negative consequences for metabolic, cardiovascular, and mental health, as well as elevated risk of cancer. Scientific advances over the past decade have shed light on key aspects of the underlying biological mechanisms. With a focus on recent human studies, this paper reviews novel insights into what drives the adverse health consequences of circadian misalignment due to night shift work. Recent Findings Misalignment between the central circadian pacemaker and externally driven behavioral patterns during night shift work produces a rapid uncoupling of peripheral rhythms, reflected in the cargo of exosomes and other signaling mechanisms, and causes conflict between central and peripheral regulatory mechanisms. This endogenous internal desynchrony has been shown to be linked to shifted meal timing and, in part, may be mediated by the gut microbiome. Endogenous internal desynchrony leads to insulin resistance – a manifestation of metabolic dysfunction. It perturbs the cardiometabolic and immune systems, and also erodes mental health. At the cellular level, mistimed DNA repair mechanisms leave residual DNA damage after exposure to a night shift schedule – which, over time, may result in genomic instability and ultimately carcinogenesis. Summary A systems biology perspective serves to elucidate how the effects of endogenous circadian disruption from night shift work increase the risk of acute and chronic illnesses. Internal desynchrony, endogenous in nature, is a common underlying cause. Time-restricted eating may help to address metabolic dysfunction due to night shift work; countermeasures for other negative health outcomes, including cancer and mental health disorders, remain to be developed.

  • Open Access

    ScreenDMT reveals metabolites replicably associated with sleep disorders across three human cohorts

    by Jonathan M Dreyfuss, Dhruv Dubey, Yu Zhang, Michael R Brown, Jerome I Rotter, Stephen S Rich, Peter Y Liu, Susan Redline, Heming Wang, Robert E Gerszten, et al.

    Replication of scientific findings across independent studies is essential, yet it remains challenging in high-dimensional biological datasets. A critical aspect of true replication requires detecting not only the repeated presence but also the consistent direction of an effect. Traditional methods for evaluating replication often ignore effect directionality or lack adequate statistical power when adjusting for multiple comparisons. To address this, we extend the directional MaxP test (DMT) and our screening-integrated procedure, ScreenDMT, to evaluate directional replication across an arbitrary number of independent studies. We mathematically prove ScreenDMT’s validity for an arbitrary number of studies when the studies’ sample sizes grow unbounded. Through extensive simulation studies, we demonstrate that ScreenDMT effectively controls error rates, such as the false discovery rate (FDR), in finite sample sizes and yields higher statistical power than competing methods especially for three studies. We applied the extended ScreenDMT to untargeted blood metabolomics profiles across three diverse human cohorts—ARIC (N=1,337), MESA (N=1,874), and HCHS/SOL (N=6,180)—to discover replicable biomarkers for dichotomous insomnia, long sleep, short sleep, and excessive daytime sleepiness (EDS). We found low levels of cortisol to be replicably associated with EDS, and high levels of n-formylmethionine to be associated with long sleep. Furthermore, directional pathway analysis revealed that low levels of xanthine metabolites are replicably associated with insomnia. These convergent findings validate ScreenDMT as a powerful methodology for simultaneous multi-cohort replication and offer insights into the metabolic signatures underlying sleep disorders across diverse populations.

  • Open Access

    Building Families—Implementing Balanced Sexual and Reproductive Health

    by Peter Y. Liu, Edgar Mocanu, Linda Giudice, Marcos Horton, Meletios P. Nigdelis, Antti Perheentupa, Andrea Sansone, Giovanni Corona, Luca Gianaroli, Dimitrios G. Goulis

    One of the main initiatives of the World Health Organization (WHO) is the promotion of Sexual and Reproductive Health (SRH). Sexuality, infertility, and contraception are three interconnected pillars of SRH, each essential for achieving global equity in family planning and family building. This scientific Statement , jointly developed by the International Federation of Fertility Societies (IFFS) and the International Society of Andrology (ISA), advocates for inclusive, evidence‐based care for all individuals and couples, regardless of geography or socioeconomic status. The Statement underscores the need to enhance practitioner and policymaker education to support access to infertility evaluations and treatments for both men and women and to promote the availability of comprehensive contraceptive services for all in need. The Statement addresses three core domains: sexuality, infertility, and contraception. It emphasizes a biopsychosocial approach to SRH, highlighting the complex interplay between sexual function and fertility. Infertility is a multifactorial condition requiring early, holistic, and multidisciplinary management, including integrated male and female evaluations, medically assisted reproduction, and fertility preservation strategies. Contraception is explored through the lens of global unmet needs, expanding options for male contraceptives, and the importance of socio‐culturally sensitive education and counseling. The joint efforts of the IFFS and ISA call for couple‐centered SRH, acknowledging the sociocultural and policy challenges that affect access to care in a region‐specific manner. This Statement aims to serve as a clinical and advocacy guide for practitioners and stakeholders, reinforcing that reproductive autonomy and access to care are vital components and duties for policymakers when developing public health strategies.

  • Open Access

    Using polygenic risk scores to evaluate definitions of self-reported sleep phenotypes across cohorts

    by Annah B Wyss, Michael Brown, Xiang Li, Brian W Spitzer, Zhijie Huang, Heming Wang, Richa Saxena, Linda C Gallo, Qibin Qi, Wassim Tarraf, et al.

    Study Objectives: Since genome-wide association studies (GWAS) of sleep phenotypes have been conducted in differing populations and definitions of sleep phenotypes vary across studies, we investigated associations between several polygenic risk scores (PRSs) and potential sleep definitions among multiethnic cohorts. Materials and Methods: Using data from four cohorts (HCHS/SOL, ARIC, MESA, BHS, N = 16 895), we considered multiple definitions of short and long sleep, insomnia, and excessive daytime sleepiness (EDS). Polygenic risk scores (PRSs) were developed based on summary statistics from GWAS in European ancestry individuals from the UK Biobank (UKB) and from GWAS conducted in a multiethnic population from the Million Veteran Program (MVP). Study-specific analyses estimated associations between sleep PRSs and corresponding sleep measures per 1 standard deviation increase in the PRS. Models were adjusted for age, sex, ancestral principal components, and center and race as appropriate. Results were meta-analyzed across studies. Results: PRSs based on European ancestry UKB GWAS had statistically significant associations with multiple definitions of the corresponding sleep phenotypes. Associations that were most consistent across studies included: short sleep PRS with ≤6 hours (OR = 1.23, p = 1.80x10-7, phet = 0.97); long sleep PRS with ≥9 hours (OR = 1.09, p = 6.76x10-4, phet = 0.77); insomnia PRS with the Women’s Health Initiative Insomnia Rating Scale (WHIIRS) ≥10 or a subset of three questions ≥6 in ARIC (OR = 1.17, p = 5.51x10-10, phet = 0.69); and EDS PRS with Epworth Sleepiness Scale (ESS) ≥11 (OR = 1.23, p = 1.83x10-13, phet = 0.83). PRSs based on multi-ancestry MVP GWAS had weaker associations compared to those based on European ancestry only. Conclusions: By evaluating several types of sleep PRSs and sleep phenotypes, we were able to highlight which sleep PRS performed well across diverse populations and which sleep definitions better captured genetic underpinnings.


  • Open Access

    Genome-wide gene by sleepiness interaction analysis for sleep apnea

    by Pavithra Nagarajan, Nuzulul Kurniansyah, Jiwon Lee, Sina A Gharib, Yushan Xu, Yiyan Zhang, Brian Spitzer, Tariq Faquih, Hufeng Zhou, Eric Boerwinkle, et al.

    Study Objectives: Excessive daytime sleepiness (EDS), influenced by environmental and social-behavioral factors, is reported by a subset of patients with sleep apnea—a group that may be at elevated cardiovascular risk. However, it is unclear whether sleep apnea with and without EDS have distinct genetic underpinnings. In this study, we perform gene-by-EDS interaction analyses for apnea hypopnea index, a diagnostic marker of sleep apnea severity, to understand EDS’s influence on its underlying genetic risk. Methods: Discovery interaction analyses for common variants and gene-based rare variants were conducted respectively using multi-ethnic Trans-Omics for Precision Medicine (N = 11 619) data, followed by replication and subsequent meta-analysis in additional Trans-Omics for Precision Medicine-imputed data (N = 8904). The 1 degree-of-freedom (1df) G × E test and the 2df joint G,G × E tests were utilized. Sex-stratified analyses were additionally performed. Results: Discovery analysis revealed two common intronic variants—rs13118183 (CCDC3) and rs281851 (MARCHF1)—and three rare variant gene sets mapped to SCUBE2, TMEM26, and CPS4FL—to exhibit interaction with EDS. Meta-analysis revealed EDS interaction with 11 rare variant gene sets mapped to UBLCP1, MED31, RAP1GAP, CPNE5, MYMX, YY1, ZNF773, YBEY, IQCB1, PI4K2B, and CORO1A. Conclusion: Genetic loci reveal connections to cardiovascular risk, insulin resistance, thiamine deficiency, and resveratrol mechanism. Discovered genetic signals may offer insight into pertinent biological pathways for sleep apnea patients with an excessively sleepy subtype. Statement of Significance Sleep apnea is a complex sleep disorder. Exemplifying this is the disparately varying estimates of presence of excessive daytime sleepiness (EDS) in patients, and persistent EDS that lingers despite treatment. Some data indicate that the excessively sleepy subtype of sleep apnea carries heightened cardiovascular risk. Whether EDS influences genetic risk factors underlying sleep apnea has not yet been investigated. This study addresses this gap, as the first genome-wide gene × EDS interaction study for apnea hypopnea index, the standard sleep apnea severity metric. Genetic loci that have been previously unconsidered for sleep apnea are revealed. Discovered interaction signals highlight pathways in metabolism, genes associated with cardiometabolic traits, and therapeutic agents influencing obesity, blood pressure, oxidative stress, and apnea hypopnea index.


  • Open Access

    Methylation risk score of C-reactive protein associates sleep health with related health outcomes

    by Ziqing Wang, Danielle A. Wallace, Brian W. Spitzer, Tianyi Huang, Kent D. Taylor, Jerome I. Rotter, Stephen S. Rich, Peter Y. Liu, Martha L. Daviglus, Lifang Hou, et al.

    C-reactive protein (CRP) reflects inflammation status and is linked to poor sleep, metabolic and cardiovascular health. Methylation (MRS) and polygenic risk scores (PRS) reflect long-term systemic inflammation, and genetically-determined CRP, respectively. To refine understanding of inflammation-linked sleep and health outcomes, we construct PRS-CRPs using GWAS summary statistics and a previously-developed MRS-CRP in the Hispanic Community Health Study/Study of Latinos. Via survey-weighted linear regression, we estimate associations between blood-, PRS-, and MRS-CRP, with multiple sleep and health outcomes (n = 2217). MRS-CRP and PRS-CRPs are associated with increasing blood-CRP level by 43% and 23% per standard deviation. MRS-CRP is associated with obstructive sleep apnea (OSA) traits, long sleep duration, diabetes and hypertension, while PRS-CRPs were not. Blood-CRP level is associated with sleep duration and diabetes. Adjusting for MRS-CRP weakens OSA-diabetes/hypertension associations. Consequently, MRS-CRP is a stronger marker than blood-CRP and PRS-CRP to systemic inflammation associated with poor sleep and related comorbidities.


  • A large-scale genome-wide study of gene-sleep duration interactions for blood pressure in 811,405 individuals from diverse populations

    by Pavithra Nagarajan, Thomas W. Winkler, Amy R. Bentley, Clint L. Miller, Aldi T. Kraja, Karen Schwander, Songmi Lee, Wenyi Wang, Michael R. Brown, John L. Morrison, et al.

    Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discovered 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes’ functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.